Anavex Life Sciences
AVXL
#8575
Rank
NZ$0.42 B
Marketcap
NZ$4.57
Share price
1.57%
Change (1 day)
-70.43%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$80.65 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$91.4 Million a decrease over its 2023 earnings that were of -NZ$79.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$80.65 Million-11.76%
2024 -NZ$91.4 Million14.77%
2023 -NZ$79.64 Million-17.49%
2022 -NZ$96.52 Million22.96%
2021 -NZ$78.5 Million35.36%
2020 -NZ$57.99 Million12.65%
2019 -NZ$51.48 Million29.09%
2018 -NZ$39.88 Million36.33%
2017 -NZ$29.25 Million17.11%
2016 -NZ$24.98 Million20.91%
2015 -NZ$20.66 Million-6.29%
2014 -NZ$22.05 Million337.28%
2013 -NZ$5.05 Million
2008 -NZ$9.33 Million106.01%
2007 -NZ$4.53 Million8848.98%
2006 -NZ$0.06 Million-79.99%
2005 -NZ$0.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.29 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$12.84 M-115.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.51 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.47 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA